Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer (Q33371034)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer |
scientific article |
Statements
1 reference
Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer (English)
1 reference
John R Eckardt
1 reference
Joachim von Pawel
1 reference
Zsolt Papai
1 reference
Antoaneta Tomova
1 reference
Valentina Tzekova
1 reference
Theresa E Crofts
1 reference
Sarah Brannon
1 reference
Paul Wissel
1 reference
Graham Ross
1 reference
1 reference
Identifiers
1 reference